Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition

Matti Annala, Sinja Taavitsainen, Daniel Khalaf, +17

Clinical Cancer Research

Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer

Cameron Herberts, Andrew J. Murtha, Simon Fu, +23

European Urology

UrologyGenitourinary CancerMedicineCancer GenomicsPik3ca Mutations +5

<i>BRCA2</i> , <i>ATM</i> , and <i>CDK12</i> Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression

Evan W. Warner, Cameron Herberts, Simon Fu, +15

Clinical Cancer Research

Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial

Matti Annala, Simon Fu, Jack V. W. Bacon, +25

Annals of Oncology

UrologyPhase Ii TrialGenitourinary CancerCabazitaxel Versus AbirateroneMedicine +6

Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Steven Yip, J. Connor Wells, Raphael Brandão Moreira, +16

Cancer

Real-World Outcomes of Nivolumab and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Igor Stukalin, J. Connor Wells, Jeffrey Graham, +17

Current Oncology

Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09)

Nizar M. Tannir, Maria Nirvana Formiga, Konstantin Penkov, +109

Journal of Clinical Oncology

Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)

Steven Yip, José Manuel Ruiz Morales, Frede Donskov, +17

Kidney Cancer

Subcutaneous versus intravenous nivolumab for renal cell carcinoma

Laurence Albigès, María T. Bourlon, Matías Chacón, +22

Annals of Oncology

Real world experience of immuno-oncology agents in metastatic renal cell carcinoma: Results from the IMDC.

Steven Yip, Connor Wells, Raphael Brandão Moreira, +17

Journal of Clinical Oncology

ImmunologyReal World ExperienceTumor ImmunologyOncologyCheckpoint Inhibitors +14